Abstract
The prognosis of hemophilic hemorrhages is greatly dependent on the therapy which is administered during the first three to five days. To prevent overloading of the circulation, highly active preparations of the antihemophilic factor should be available.
A survey of the recently developed concentrated products of this factor and of their suitability for clinical use is presented. The authors describe their own experiences in the treatment of a number of patients with hemophilia A by administration of so-called “two-donor” fibrinogen.
The effect of this “two-donor” fibrinogen was not inferior to results obtained else-where with the so-called I-O product, prepared from a much greater quantity of blood plasma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- LOELIGER E. H. [Experience in the treatment of patients suffering from hemophilia A with animal AHG preparations]. Ned Tijdschr Geneeskd. 1962 Mar 31;106:690–692. [PubMed] [Google Scholar]
- NIEMETZ J., WEILLAND C., SOULIER J. P. [Preparation of a human plasmatic fraction rich in factor VIII (antihemophilic A) and poor in fibrinogen]. Nouv Rev Fr Hematol. 1961 Nov-Dec;1:880–886. [PubMed] [Google Scholar]
- NITSCHMANN H., KISTLER P., JOSS A. Dried fraction I for clinical use from smallest plasma pools, sterile without filtration. Vox Sang. 1957 Mar;2(2):100–103. doi: 10.1111/j.1423-0410.1957.tb03440.x. [DOI] [PubMed] [Google Scholar]
- PAVLOVSKY A., SIMONETTI C., CASILLAS G., BERGNA L. J., ANDINO A., BACHMANN A. E. The use of factor VIII freed from fibrinogen in the treatment of haemophilic patients. Br J Haematol. 1961 Jul;7:365–372. doi: 10.1111/j.1365-2141.1961.tb00346.x. [DOI] [PubMed] [Google Scholar]
- RODMAN N. F., Jr, BARROW E. M., GRAHAM J. B. Diagnosis and control of the hemophilioid states with the partial thromboplastin time (PTT) test. Am J Clin Pathol. 1958 Jun;29(6):525–538. doi: 10.1093/ajcp/29.6.525. [DOI] [PubMed] [Google Scholar]
- VAN CREVELD S., MOCHTAR I. A. Plasmatransfusies bij hemofile. VI. Nieuwe richtlijnen voor de behandeling van bloedingen bij hemofilie. Ned Tijdschr Geneeskd. 1959 Jan 31;103(5):205–210. [PubMed] [Google Scholar]
- van CREVELD, VEDER H. A., PASCHA C. N. The separation of AHF from fibrinogen. II. Thromb Diath Haemorrh. 1960 Mar 1;4:211–217. [PubMed] [Google Scholar]